Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 72.74 KB
Add to list
  1. Search results
  2. Prevalence of hepatitis A, B and C in...

Prevalence of hepatitis A, B and C in the Flemish population

M Beutels, P Van Damme, W Aelvoet, J Desmyter, F Dondeyne, C Goilav, Rudolf Mak, L Muylle, D Pierard, A Stroobant, et al.
(1997) EUROPEAN JOURNAL OF EPIDEMIOLOGY. 13(3). p.275-280
Author
Organization
Abstract
Viral hepatitis is a serious health problem throughout the world. No recent prevalence data on hepatitis A, B and C were available for the population in Flanders, Belgium. For this reason, a sero-epidemiological study was undertaken in 1993-1994 in a sample of the general population. The purpose of this study was to obtain a clear picture of the prevalence of hepatitis A, B and C. Between April 1993 and February 1994, 4,058 blood samples were drawn and collected in 10 hospitals in Flanders. The study group was representative for the FIemish population. For hepatitis A a seroprevalence of 55.1% was found. In the non-Belgian residents the HAV prevalence was significantly higher than in Belgians (62% versus 52%; chi(2) = 8.05; p = 0.005). For hepatitis B, 9.9% of the study group showed serological evidence of hepatitis B markers: 6.9% of the participants was positive for anti-HBs/anti-HBc, 0.7% appeared to be HBsAg positive and 3.5% was solely anti-HBs positive. The prevalence of HBV markers in Belgians was 6.9%, significantly lower compared to the 13.4% among non-Belgians (chi(2) = 14.05; p = 0.00018). 4055 serum samples were analysed for hepatitis C serology by second generation anti-HCV tests. Anti-HCV was detected in 0.87% of the serum samples. No statistically significant difference was found in HCV prevalence between Belgians and non-Belgians. Results of this study should help policy makers in their decisions on the most appropriate hepatitis A and B vaccination strategy and on the most effective prevention strategy for hepatitis C.
Keywords
prevalence study, hepatitis C (HCV), hepatitis B (HBV), hepatitis A (HAV), Flemish population

Downloads

  • Download
    (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 72.74 KB

Citation

Please use this url to cite or link to this publication:

MLA
Beutels, M., et al. “Prevalence of Hepatitis A, B and C in the Flemish Population.” EUROPEAN JOURNAL OF EPIDEMIOLOGY, vol. 13, no. 3, 1997, pp. 275–80, doi:10.1023/A:1007393405966.
APA
Beutels, M., Van Damme, P., Aelvoet, W., Desmyter, J., Dondeyne, F., Goilav, C., … Vranckx, R. (1997). Prevalence of hepatitis A, B and C in the Flemish population. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 13(3), 275–280. https://doi.org/10.1023/A:1007393405966
Chicago author-date
Beutels, M, P Van Damme, W Aelvoet, J Desmyter, F Dondeyne, C Goilav, Rudolf Mak, et al. 1997. “Prevalence of Hepatitis A, B and C in the Flemish Population.” EUROPEAN JOURNAL OF EPIDEMIOLOGY 13 (3): 275–80. https://doi.org/10.1023/A:1007393405966.
Chicago author-date (all authors)
Beutels, M, P Van Damme, W Aelvoet, J Desmyter, F Dondeyne, C Goilav, Rudolf Mak, L Muylle, D Pierard, A Stroobant, F Van Loock, P Waumans, and R Vranckx. 1997. “Prevalence of Hepatitis A, B and C in the Flemish Population.” EUROPEAN JOURNAL OF EPIDEMIOLOGY 13 (3): 275–280. doi:10.1023/A:1007393405966.
Vancouver
1.
Beutels M, Van Damme P, Aelvoet W, Desmyter J, Dondeyne F, Goilav C, et al. Prevalence of hepatitis A, B and C in the Flemish population. EUROPEAN JOURNAL OF EPIDEMIOLOGY. 1997;13(3):275–80.
IEEE
[1]
M. Beutels et al., “Prevalence of hepatitis A, B and C in the Flemish population,” EUROPEAN JOURNAL OF EPIDEMIOLOGY, vol. 13, no. 3, pp. 275–280, 1997.
@article{271652,
  abstract     = {{Viral hepatitis is a serious health problem throughout the world. No recent prevalence data on hepatitis A, B and C were available for the population in Flanders, Belgium. For this reason, a sero-epidemiological study was undertaken in 1993-1994 in a sample of the general population. The purpose of this study was to obtain a clear picture of the prevalence of hepatitis A, B and C. Between April 1993 and February 1994, 4,058 blood samples were drawn and collected in 10 hospitals in Flanders. The study group was representative for the FIemish population. For hepatitis A a seroprevalence of 55.1% was found. In the non-Belgian residents the HAV prevalence was significantly higher than in Belgians (62% versus 52%; chi(2) = 8.05; p = 0.005). For hepatitis B, 9.9% of the study group showed serological evidence of hepatitis B markers: 6.9% of the participants was positive for anti-HBs/anti-HBc, 0.7% appeared to be HBsAg positive and 3.5% was solely anti-HBs positive. The prevalence of HBV markers in Belgians was 6.9%, significantly lower compared to the 13.4% among non-Belgians (chi(2) = 14.05; p = 0.00018). 4055 serum samples were analysed for hepatitis C serology by second generation anti-HCV tests. Anti-HCV was detected in 0.87% of the serum samples. No statistically significant difference was found in HCV prevalence between Belgians and non-Belgians. Results of this study should help policy makers in their decisions on the most appropriate hepatitis A and B vaccination strategy and on the most effective prevention strategy for hepatitis C.}},
  author       = {{Beutels, M and Van Damme, P and Aelvoet, W and Desmyter, J and Dondeyne, F and Goilav, C and Mak, Rudolf and Muylle, L and Pierard, D and Stroobant, A and Van Loock, F and Waumans, P and Vranckx, R}},
  issn         = {{0393-2990}},
  journal      = {{EUROPEAN JOURNAL OF EPIDEMIOLOGY}},
  keywords     = {{prevalence study,hepatitis C (HCV),hepatitis B (HBV),hepatitis A (HAV),Flemish population}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{275--280}},
  title        = {{Prevalence of hepatitis A, B and C in the Flemish population}},
  url          = {{http://doi.org/10.1023/A:1007393405966}},
  volume       = {{13}},
  year         = {{1997}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: